Using economic threshold analysis to determine the intensity of HIV prevention services for HIV-seropositive persons

AIDS

Volumn 19, Issue 17, 2005, Pages 2025-2029

  Holtgrave, David R ^a,b  

^a EMORY UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; Economics; HIV; HIV seropositivity; Prevention

Indexed keywords

ARTICLE; CALCULATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COUNSELING; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PRIORITY JOURNAL; SOCIETY; UNITED STATES; VIRUS TRANSMISSION;

EID: 27944432137     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000191926.62302.52     Document Type: Article

References (24)

1. CDC. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Weekly 2003; 52:329-332.
2. DiClemente RJ, Wingood GM, del Rio C, Crosby RA. Prevention interventions for HIV positive individuals. Sex Transm Infect 2002; 78:393-395.
3. Gordon C, Forsyth AD, Stall R, Cheever LW. Prevention interventions with persons living with HIV/AIDS: State of the science and future directions. AIDS Educ Prev 2005; 17(Suppl A):6-20.
4. Kalichman SC, Rompa D, Luke W, Austin J. HIV transmission risk behaviours among HIV-positive persons in serodiscordant relationships. Int J STD & AIDS 2002; 13:677-682.
5. Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol 2003; 22:223-228.
6. Rotheram-Borus MJ, Lee MB, Murphy DA, Futterman D, Duan N, Birnbaum JM, et al. Efficacy of a prevention intervention for youths living with HIV. Am J Public Health 2001; 91:400-405.
7. Kalichman SC, Rompa D, Cage M, DiFonzo K, Simpson D, Austin J, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med 2001; 21:84-92.
8. Patterson TL, Shaw WS, Semple SJ. Reducing the sexual risk behaviors of HV+ individuals: Outcome of a randomized controlled trial. Ann Behav Med 2003; 25:137-145.
9. CDC. Advancing HIV Prevention: The science behind the new initiative. http://www.cdc.gov/hiv/partners/ahp_science.htm [Accessed on 30 June 2004].
10. DiFranceisco W, Kelly JA, Otto-Salaj L, McAuliffe TL, Somlai AM, Hackl K, et al. Factors influencing attitudes within AIDS service organizations toward the use of research-based HIV prevention interventions. AIDS Educ Prev 1999; 11:72-86.
11. Holtgrave DR, Quails NL, Graham JD. Economic evaluation of HIV prevention programs. Annu Rev Public Health 1996; 17:467-488.
12. Tuli K, Sansom SL. The INSPIRE Team. Economic evaluation of an HIV prevention intervention with seropositive injection drug users. Presented at the 2003 National HIV Prevention Conference, Atlanta, Georgia, July 2003 [abstract #M1-E0601]).
13. Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
14. Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS & Behav 1998; 2:189-201.
15. Holtgrave DR, Qualls NL. Threshold analysis and programs for prevention of HIV infection. Med Decis Making 1995; 15:311-317.
16. Norton EC, Martin RF, Wechsberg WM. Threshold analysis of AIDS outreach and intervention. In: Handbook of Economic Evaluation of HIV Prevention Programs. Edited by Holtgrave DR. New York: Plenum Press; 1998. pp. 195-209.
17. Pinkerton SD, Holtgrave DR, DiFranceisco WJ, Semaan S, Johnson-Masotti AP. Cost-threshold evaluation of the NADR HIV prevention interventions. Presented at the National HIV Prevention Conference, Atlanta, Georgia, August-September 1999 [abstract no. 397].
18. Holtgrave DR. Estimation of annual HIV transmission rates in the United States, 1978-2000. J Acquir Immune Defic Syndr 2004; 35:89-92.
19. Holtgrave DR, Anderson T. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. Int J STD & AIDS 2004; 15:789-792.
20. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Human Retrovirol 1997; 16:54-62.
21. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index - Medical Care (seasonally adjusted, US city average). http://data.bls.gov/ labjava/outside.jsp?survey=cu (Accessed on 1 July 2004].
22. Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, Farnham PG. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. AIDS 2001; 15:917-928.
23. Holtgrave DR, Pinkerton SD, Merson M. Estimating the cost of unmet HIV prevention needs in the United States. Am J Prev Med 2002; 23:7-12.
24. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index - All Items (seasonally adjusted, US city average http://data.bls.gov/labjava/ outside.jsp?survey=cu [Accessed on 1 July 2004].